Insulet Correlations
| PODD Stock | USD 287.36 1.27 0.44% |
The current 90-days correlation between Insulet and DexCom Inc is 0.3 (i.e., Weak diversification). The correlation of Insulet is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Insulet Correlation With Market
Modest diversification
The correlation between Insulet and DJI is 0.24 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Insulet and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Insulet Stock
| 0.74 | 688606 | Hangzhou Alltest Biotech | PairCorr |
| 0.62 | 002382 | Blue Sail Medical | PairCorr |
| 0.65 | ELAB | Elevai Labs, Common | PairCorr |
| 0.77 | EMBC | Embecta Corp | PairCorr |
Moving against Insulet Stock
| 0.36 | DXCM | DexCom Inc Sell-off Trend | PairCorr |
| 0.68 | ELMD | Electromed | PairCorr |
| 0.67 | EDAP | EDAP TMS SA | PairCorr |
| 0.45 | BLCO | Bausch Lomb Corp | PairCorr |
| 0.55 | FIGS | Figs Inc | PairCorr |
| 0.46 | ALC | Alcon AG | PairCorr |
| 0.37 | 601089 | Beijing Winsunny Pha | PairCorr |
| 0.34 | ESTA | Establishment Labs | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Insulet Stock performing well and Insulet Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Insulet's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DXCM | 1.68 | (0.03) | (0.01) | 0.03 | 3.64 | 3.10 | 17.38 | |||
| STE | 0.86 | 0.04 | (0.01) | 0.21 | 1.02 | 1.91 | 9.76 | |||
| PHG | 1.11 | (0.07) | 0.00 | (0.02) | 0.00 | 2.06 | 8.74 | |||
| ZBH | 1.27 | (0.15) | 0.00 | (0.20) | 0.00 | 3.30 | 18.60 | |||
| BIIB | 1.41 | 0.34 | 0.20 | 0.60 | 1.25 | 2.98 | 13.74 | |||
| LH | 1.14 | (0.18) | 0.00 | (0.26) | 0.00 | 1.74 | 7.53 | |||
| WAT | 1.34 | 0.36 | 0.30 | 0.51 | 0.78 | 3.59 | 9.50 | |||
| WST | 1.56 | 0.02 | 0.01 | 0.09 | 1.61 | 3.46 | 14.90 | |||
| SNN | 1.07 | (0.17) | 0.00 | (0.12) | 0.00 | 2.29 | 14.66 | |||
| DGX | 0.99 | (0.11) | 0.00 | (0.26) | 0.00 | 1.94 | 6.40 |
Insulet Corporate Management
| Philip Hildale | Senior Care | Profile | |
| Andrew Isaacson | Senior Development | Profile | |
| Laetitia Cousin | Quality Affairs | Profile | |
| Carolyn Sleeth | Senior Manager | Profile |